NFKB1 and breast carcinoma: The anti-metastatic action of curcumin in breast cancer cells is explained by its inhibition of the nuclear translocation of NF-κB via dephosphorylation of IκB, resulting in the down-regulation of inflammation-related cytokines, such as CXCL1/2 [224].